you mist the next part in your quest to quickly downramp as normal
“We want to reduce the frequency of the lesions,” he said.
How it works ... the vaccine will treat herpes simplex, further testing is needed to see if it prevents the spread of the virus. Picture: Supplied Source: Supplied
Over time the trials will be extended to test whether the vaccine also works to prevent the spread of the virus but this type of study takes a long period and must involve lots of people.
The Phase 1 trial produced a T-cell response in 95 per cent of the humans it was tested in.
T cells are killer cells that detect cells infected with a virus and kill them.
The study found variable evidence that the vaccine produced and antibody response to herpes simplex.
you mist the next part in your quest to quickly downramp as...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |